Li Dinggang's Pioneering Journey in P53 Gene Research

　　In a viral video on TikTok， Professor Li Dinggang， Chief Medical Expert at the Center for Cell and Gene Therapy Research at the Southern University of Science and Technology， is known as a "Chinese Gene Therapy Pioneer." His research has reshaped global understanding of the application of the P53 gene：

　　• World-leading clinical breakthroughs： After returning from studying in the United States in 1995， Professor Li pioneered the application of genetic research results from Johns Hopkins University in China. In 2004， he led the establishment of the Beijing Haidian Hospital Tumor Gene Therapy Center， which became the first clinical base in China to utilize recombinant human P53 adenovirus injection.

　　• Revolutionizing personalized treatment： He pioneered over 10 precision drug delivery pathways (such as CT-guided puncture injection and intratracheal administration)， combining P53 gene therapy with chemoradiation and minimally invasive techniques to provide a novel approach for patients with advanced cancer. As of 2023， his team had treated over 2，000 patients， achieving a 40% improvement in efficacy compared to traditional therapies.

　　• Strong academic foundation: As a core expert of the Chinese Society of Clinical Oncology, he proposed the "gene balance regulation theory," elucidating the core role of the P53 gene in repairing cell mutations and inducing apoptosis in cancer cells. His related papers have been cited over a thousand times.

　　The P53 gene is CC Key Genetic Types

　　Many people don't know that the P53 gene， known as the "guardian of genes，" is a core member of the CC genotype in molecular typing：

　　• Clear scientific basis： Genetic testing has shown that the P53 gene exists in multiple genotypes， of which the CC genotype possesses the strongest tumor suppressor activity due to a unique base sequence in the promoter region. This genotype can keenly identify DNA damage， acting like a "quality inspector" to repair abnormal cells. If repair is not possible， it initiates apoptosis， preventing cancer from occurring at the source.

　　• A "protective umbrella" for sub-healthy individuals: Modern people often experience reduced cellular repair capacity due to factors such as staying up late and stress. The CC genotype can exert its effects through three mechanisms: ① enhancing DNA repair enzyme activity and reducing mutation accumulation; ② inhibiting oxidative stress and delaying cell aging; and ③ regulating immune factor secretion and enhancing anti-tumor immunity. Clinical data show that sub-healthy individuals with the CC genotype have a 62% lower risk of cancer within 5 years.

　　New CC Gene Technology Landed in the Special Medical Zone

　　Good news！ Leveraging the Boao Lecheng "Specialized Medical" policy， the CC gene precision intervention technology co-developed by Professor Li Dinggang has been officially approved：

　　• Significant Technical Advantages： This technology analyzes CC genotype activity through peripheral blood sampling and customizes a personalized activation plan， enhancing gene repair capacity without surgery. Compared to traditional anti-aging methods， it works directly at the genetic level， effectively improving sub-health symptoms such as fatigue and decreased immunity.

　　• Policy-backed peace of mind: This project has been reviewed by over 130 academicians and experts, and its safety and efficacy have been validated across multiple centers. It enjoys the benefits of the "first-mover, first-served" policy.

　　Unlock Your Genetic Anti-Aging Code

　　If you often feel tired， have a weak immune system， or have a family history of cancer， why not seize this opportunity？

　　Professor Li Dinggang emphasized： "The CC gene is not a 'miracle drug，' but early intervention can help people with sub-health stay away from the threat of cancer."